Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CDC Chooses Five Laboratories For Pathogen Genomics Network

Executive Summary

The CDC’s $90m funding will be split among five laborites across the US over five years as a part of its pioneering Pathogen Genomics Centers of Excellence Network.

You may also be interested in...



Da Vinci Surgical Robot Insulation Defects Led To Florida Woman’s Death, Lawsuit Alleges

Intuitive Surgical is facing claims that malfunctions of its da Vinci surgical robot led to a woman’s death following a laparoscopic surgery.

Masimo’s MightySat Receives First FDA Clearance For OTC Pulse Oximeter

The first clearance from the US Food and Drug Administration for an over-the-counter fingertip pulse oximeter has gone to Masimo's MightySat Medical, which is now available at the company's website.

HHS Releases ‘Essential’ And ‘Enhanced’ Cybersecurity Performance Goals

HHS publishes a new website and releases its essential and enhanced voluntary cybersecurity performance goals.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT145881

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel